Legal Opinion
Senju Pharmaceutical Co. v. Apotex, Inc.
District Court, D. Delaware
Decided February 6, 2013No. Civ. No. 12-159-SLRPublishedCited by 30 opinions
1Opinion of the Court
MEMORANDUM OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) with the United States Food and Drug Administration (“FDA”) by defendants Apotex, Inc. and Apotex Corp. (collectively, “Apotex”). Allergan, Inc. (“Allergan”) is the holder of approved New Drug Application (“NDA”) No. 22-548 that covers Zymaxid®, a 0.5% ophthalmic solution of gatifloxacin. (D.I. 1 at ¶ 29) Senju Pharmaceutical Co., Ltd. (“Senju Pharma”), Kyorin Pharmaceutical Co., Ltd. (“Kyorin”), and Allergan (collectively, “Senju”) are the…
2Cases cited25 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Pension Benefit Guaranty Corporation v. White Consolidated Industries, Inc., C/o Ct Corporation Systems Registered AgentCourt of Appeals for the Third Circuit · 1993
20 more not listed; retrieve them via the Exa API.
3Cited by30 opinions
- Rah Color Technologies LLC v. Ricoh USA Inc.District Court, E.D. Pennsylvania · 2016
- Gradient Enterprises, Inc. v. Skype Technologies S.A.District Court, W.D. New York · 2013
- AMERICAN REGENT, INC. v. SOMERSET THERAPEUTICS, LLCDistrict Court, D. New Jersey · 2025
- Allergan USA, Inc. v. MSN Laboratories Private LimitedDistrict Court, D. Delaware · 2022
- Analog Devices, Inc. v. Xilinx, Inc.District Court, D. Delaware · 2021
25 more not listed; retrieve them via the Exa API.